Surgical resection of adrenal neoplasias with endocrine activity is pr
incipally indicated. In adrenal neoplasias without endocrine activity,
surgical removal is indicated in relation to tumor size. Surgical acc
ess and extent of resection are the major problems related to adrenal
surgery. From 1980 to 1996, in 154 patients (62 m, 92 f) primary and u
nilateral adrenal tumors (139 benign, 15 malign) were resected. 93 res
ections were performed transperitoneally, 13 extraperitoneally, and 48
retroperitoneoscopically. Subtotal adrenal resections were performed
in 23 benign tumors smaller than 4 cm. Perioperative lethality was 0 %
, morbidity was 31,8 %. Malignancy was correlated to tumor size: In 11
4 tumors smaller than 5 cm, no malign neoplasia was found, whereas in
40 tumors larger than 5 cm, 15 specimen were malign. Operating time of
the retroperitoneoscopic method was significantly longer than of open
procedures (p<0,05). Postoperative analgetic medication was significa
ntly reduced after endoscopic surgery compared to transperitoneal or e
xtraperitoneal surgery (p<0,0001). No tumor recurrences occurred after
subtotal adrenal resections (mean follow up: 5,7 [1,3 years]). In pat
ients with adrenal carcinomas, 5-year-survival was approximately 15 %.
In adrenal neoplasias smaller than 5 cm, malignancy is extremely rare
. Therefore, less aggressive surgery with a lower morbidity (extraperi
toneal approach) and reduced postoperative pain (retroperitoneoscopic
approach) including function preserving resection is indicated in thes
e lesions. Due to the high incidence of malignancy, adrenal tumors lar
ger than 5 cm should principally be treated by conventional transperit
oneal surgery.